Pharmacokinetics, Safety, and CCR2/CCR5 Antagonist Activity of Cenicriviroc in Participants With Mild or Moderate Hepatic Impairment

E. Lefebvre, M. Gottwald, K. Lasseter, W. Chang, M. Willett, P. F. Smith, A. Somasunderam, N. S. Utay

Research output: Contribution to journalArticlepeer-review

35 Scopus citations

Fingerprint

Dive into the research topics of 'Pharmacokinetics, Safety, and CCR2/CCR5 Antagonist Activity of Cenicriviroc in Participants With Mild or Moderate Hepatic Impairment'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences